Latina Pharma S.P.A. [Sermoneta / Italy]

Latina Pharma S.P.A. [Sermoneta / Italy] located in SERMONETA LAZIO, Italy under the [International Chemical Investors S.E.] organization had its last known inspection on 19 Jan 2024. There are 19 known inspections on record.

Site Details

Industries:
Human Drugs
Tags:
Human Drugs, Packaging, FDF Manufacturer, Manufacturer, Label, API Manufacturer, Analytical Testing, Non-Sterile, Sterile
Parent Organization:
International Chemical Investors S.E.
Last Inspection Date:
19 Jan 2024
FEI:
3001229385
Redica ID:
100014262
Investigators:
Linda F Murphy, Paul L Figarole, Jr, Justin A Boyd, Luella J Rossi, Susan M Jackson, Russell J Glapion, Xiaoping Guan, Mra Mcculloughj, Raymond T Oji, Meyer J Slobotsky, Amir Alavi, Caryn M Mcnab, Richard L Friedman, Paul Mouris, David K Lau

Latina Pharma S.P.A. [Sermoneta / Italy]'s Most Recent Documents

Publish Date Document Type Title
September, 2019 EIR Latina Pharma S.P.A. - EIR, 2019-09-27
April, 2017 FDA 483 Latina Pharma S.P.A. - Form 483, 2017-04-21
May, 2015 FDA 483 Latina Pharma S.P.A. - Form 483, 2015-05-29
August, 2003 EIR Latina Pharma S.P.A. - EIR, 2003-08-01
July, 2003 FDA 483 Response Latina Pharma S.P.A. - Form 483R, 2003-07-16

Experience Redica Systems’ NEW site dashboards and profiles

Redica Systems customers can leverage the full Quality and Regulatory Intelligence suite, with powerful analysis covering thousands of sites around the world. You can search by FEI, or more powerfully, by the Redica ID, our universal identifier for global life sciences manufacturing sites, an industry first.

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Site Profile Icon

Loading...

Site Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to our extensive inventory of site profiles, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more